Teva
Teva releases financials, shares fall off cliff, plans to axe 7000 jobs
August 3, 2017Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
Teva has released its second quarter financials and they do not make for great reading if you’re an investor. The …
Department of Health appoints Teva and Sanofi veteran as commercial head
July 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, Sanofi, Teva, biotech, drugs, government, healthcare, pharma, pharmaceuticals
The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …
Teva to cut over 300 production jobs in Israel
July 24, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, generics, healthcare, pharma, pharmaceutical
Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash …
Top Ten most popular articles on Pharmafile.com this week
July 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten
The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …
Teva asthma treatment scores NICE approval
July 20, 2017Sales and Marketing Teva, asthma, biotech, cinqaero, drugs, healthcare, pharma, pharmaceuticals
NICE has reached a decision in its final appraisal determination of Teva’s Cinqaero (reslizumab), recommending the drug’s use as an …
AstraZeneca’s Soriot Teva switch scotched
July 17, 2017Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical
The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …
AstraZeneca’s CEO set for shock switch to Teva
July 13, 2017Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical
It is no secret that Teva has been on the lookout for a new CEO and they had already been …
Teva accuses ex-employee of passing company secrets to boyfriend at rival generics firm
July 12, 2017Research and Development, Sales and Marketing Apotex, Teva, biotech, drugs, generics, healthcare, pharma, pharmaceuticals
Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …
FDA approves first generic versions of Lilly’s ADHD drug
May 31, 2017Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva
The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …
500 staff face the axe as Teva cans Hungary plant
May 18, 2017Manufacturing and Production Teva
Israeli pharmaceutical firm Teva has announced that it plans to cease operations at a manufacturing plant in Gödöllő in Budapest, …
Teva and Active Biotech hit by Phase 3 drug failure
May 8, 2017Research and Development, Sales and Marketing Active Biotech, Teva
Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …
Teva has another high profile role to fill
April 27, 2017Sales and Marketing Eyal Desheh, Teva, Teva Pharmaceuticals
Teva’s gaps at the top level of its structure continue to build, as Eyal Desheh is set to leave his …
Teva launches competitors to GSK’s Advair inhaler
April 21, 2017Medical Communications, Sales and Marketing Advair, AirDuo, GSK, Teva, asthma
GSK has been anticipating competition to its Advair for two years and Teva has announced that it will be the …
Teva’s Huntington’s treatment becomes first FDA-approved deuterated drug
April 4, 2017Manufacturing and Production, Sales and Marketing Austedo, FDA, Teva
Israel’s Teva Pharmaceuticals has announced that the FDA has given its approval for Austedo (deutetrabenazine) in the treatment of chorea …
Pfizer plant receives FDA warning letter for contamination of medicine
March 1, 2017Manufacturing and Production Copaxone, Mylan, Pfizer, Teva, generics
The FDA has issued a warning letter to Pfizer after inspectors discovered that the plant did not protect properly against …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
